Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Park, Christopher Y  [Clear All Filters]
2013
Abdel-Wahab O, Gao J, Adli M, Dey A, Trimarchi T, Chung YRock, Kuscu C, Hricik T, Ndiaye-Lobry D, Lafave LM, et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J Exp Med. 2013.
Deshpande S, Bosbach B, Yozgat Y, Park CY, Moore MAS, Besmer P. Kit receptor gain-of-function in hematopoiesis enhances stem cell self-renewal and promotes progenitor cell expansion. Stem Cells. 2013.
2014
Shin JY, Hu W, Naramura M, Park CY. High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. J Exp Med. 2014.
Khalaj M, Tavakkoli M, Stranahan AW, Park CY. Pathogenic microRNA's in myeloid malignancies. Front Genet. 2014;5:361.
2021
Niizuma H, Searleman AC, Takeda S, Armstrong SA, Park CY, Cheng EH, Hsieh JJ. Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates through cleaving TFIIA. JCI Insight. 2021.
2022
Chakraborty S, Park CY. Pathogenic Mechanisms in Acute Myeloid Leukemia. Curr Treat Options Oncol. 2022.
2023
Ravn-Boess N, Roy N, Hattori T, Bready D, Donaldson H, Lawson C, Lapierre C, Korman A, Rodrick T, Liu E, et al. The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability. Cell Rep. 2023;42(11):113374.
Remark LH, Leclerc K, Ramsukh M, Lin Z, Lee S, Dharmalingam B, Gillinov L, Nayak VV, Parente PEl, Sambon M, et al. Loss of Notch signaling in skeletal stem cells enhances bone formation with aging. Bone Res. 2023;11(1):50.
2024
Saito Y, Yang Y, Saito M, Park CY, Funato K, Tabar V, Darnell RB. NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells. Proc Natl Acad Sci U S A. 2024;121(10):e2314695121.